← All organizations
Highest phase reached
Phase 3
First clinical trial
Feb 1, 1994Last known activity
Dec 15, 2025
Timeline
1940s
- Jan 1, 1945
UNICANCER— Founded
Drugs by trial phase (144 distinct, 182 trials)
Phase 3 (83 own, 0 via acquisition)
Phase 2 (58 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Anus Neoplasms
- Bile Duct Neoplasms
- Breakthrough Pain
- Breast Neoplasms
- Carcinoma
- Carcinoma, Ductal
- Carcinoma, Hepatocellular
- Carcinoma, Neuroendocrine
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Central Nervous System Neoplasms
- Cholangiocarcinoma
- Chondroma
- Chondrosarcoma
- Choriocarcinoma
- Colonic Neoplasms
- Colorectal Neoplasms
- Depression
- Desmoid Tumors
- Disease Progression
- Endodermal Sinus Tumor
- Endometrial Neoplasms
- Esophageal Neoplasms
- Fibroma
- Gallbladder Neoplasms
- Gastrointestinal Stromal Tumors
- Germinoma
- Glioblastoma
- Head and Neck Neoplasms
- Hemangiosarcoma
- Hematologic Neoplasms
- Inflammatory Breast Neoplasms
- Kidney Neoplasms
- Leiomyosarcoma
- Lung Neoplasms
- Lymphoma
- Lymphoma, Non-Hodgkin
- Malnutrition
- Melanoma
- Meningioma
- Microsatellite Instability
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Germ Cell and Embryonal
- Neoplastic Cells, Circulating
- Nervous System Neoplasms
- Oropharyngeal Neoplasms
- Osteosarcoma
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Penile Neoplasms
- Peripheral Nervous System Diseases
- Peritoneal Neoplasms
- Prostatic Neoplasms
- Rectal Neoplasms
- Recurrence
- Salivary Gland Neoplasms
- Sarcoma
- Sarcoma, Ewing
- Seminoma
- Skin Neoplasms
- Small Cell Lung Carcinoma
- Squamous Cell Carcinoma of Head and Neck
- Stomach Neoplasms
- Teratoma
- Testicular Neoplasms
- Thyroid Neoplasms
- Ureteral Neoplasms
- Urethral Neoplasms
- Urinary Bladder Neoplasms
- Uterine Cervical Neoplasms
- Uveal Neoplasms
- Vulvar Neoplasms
Recent trials (50)
- NCT07118800Lead sponsorPhase 3Dec 15, 2025
- NCT07193394CollaboratorPhase 2Dec 5, 2025
- NCT07230613Lead sponsorPhase 2Dec 1, 2025
- NCT07237256Lead sponsorPhase 3Dec 1, 2025
- NCT07152821CollaboratorPhase 3Nov 30, 2025
- NCT06904170OfficialPhase 2/Phase 3Nov 30, 2025
- NCT06904170Lead sponsorPhase 2/Phase 3Nov 30, 2025
- NCT07151586Lead sponsorPhase 2Oct 31, 2025
- NCT07192068Lead sponsorPhase 2Oct 30, 2025
- NCT06846346Lead sponsorPhase 2Sep 30, 2025
- NCT06680596Lead sponsorPhase 2Mar 30, 2025
- NCT06625970Lead sponsorPhase 3Jan 31, 2025
- NCT06529718Lead sponsorPhase 2Jan 30, 2025
- NCT06606730Lead sponsorPhase 3Jan 1, 2025
- NCT06475352Lead sponsorPhase 2Dec 31, 2024
Details
- Founded
- Paris, FR Jan 1, 1945
- Last known activity
- Dec 15, 2025